Diabetics are facing a double wammy
It seems our diabetic population has had to face a double wammy in recent months. First it was the effects of gadodiamide contrasting agent used in MRIs and MRAs causing a rare and possibly fatal skin disease called Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Systemic Dermopathy (NSD). Then it was an article written for the New England Journal of Medicine concerning the diabetic drug Avandia that helps the body use insulin more efficiently, causing a higher risk of cardiovascular death (64% increase) and heart attacks (43% increase). As well as possibly causing macular edema, it is fluid retention in the eye that can cause vision impairment. Now the FDA is under attack by the government for not taking more extensive steps in preventing these types of drugs reaching the market without proper drug trials. It is in these times that we need to keep asking questions of our doctors. If you or loved one is experiencing kidney disease or any degree of renal failure, you may want to talk to your doctor about getting an MRI or an MRA and discuss the current gadodiamide issues. You may also want to discuss the possible risks in taking Avandia and Actos (another diabetic drug). In today’s times of insufficient and expensive health care we need to take control of our own medical issues and know the current events concerning drugs and treatments. Stay aware and stay involved.
